Active, Not Recruiting
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
NCT05276973
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +32 more
- Locations
-
- UCSF Medical Center-Mission Bay San Francisco, California, United States
- Augusta University Medical Center Augusta, Georgia, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States